-
-
-
-
-
-
-
CytoMed Therapeutics Announces Novel First-In-Human Clinical Trial Collaborations with Renowned and Prestigious Hospital Partner to Advance Its Off-The-Shelf Donor-Derived Gamma Delta T Cells Allogene
-
-
-
-
-
-
-
CytoMed Therapeutics publishes research on cancer cell therapy
-
-
-
-
-
-
-
CytoMed Therapeutics announces Chairman’s Letter to the Company’s shareholders
-
-
-
-
-
-
-
CytoMed Therapeutics completes cash acquisition of Cord Blood Banking Licence and Assets expanding CytoMed’s strategy to cord blood-derived biologics through subsidiary, LongevityBank
-
-
-
-
-
-
-
Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology
-
-
-
-
-
-
-
CytoMed Therapeutics (GDTC) Announces China Research Collaboration to Enhance its Allogeneic CAR γδ T In Vivo Persistency
-
-
-
-
-
-
-
CytoMed Therapeutics Limited Announces Collaboration with MD Anderson Cancer Center to Advance Allogeneic Off-the-Shelf Gamma Delta T Cells in Oncology
-
1,199,264 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


